Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SMTC
7. SPY
8. NCNO
9. BOX
10. CRM

Go back to Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
(NASDAQ: EOLS) Delayed: 8.78 -0.19 (2.12%)
Previous Close $8.97    52 Week High $ 
Open $8.86    52 Week Low $ 
Day High $9.08    P/E N/A 
Day Low $8.77    EPS $ 
Volume 1,512,835